Update Course Rewind 2025: Do We Still Need Routine Anal Dilations After PSARP?

Why This Practice Exists

Posterior sagittal anorectoplasty (PSARP) is the standard surgical repair for anorectal malformations — congenital conditions where the anus and rectum don't develop normally 0:21. After reconstruction, surgeons have traditionally prescribed a regimen of anal dilations: parents insert progressively larger dilators into the child's neo-anus, typically twice daily for months, to prevent stricture formation at the surgical site 0:21. For decades, every child received this protocol 0:21. The logic was straightforward — the newly created anal opening would scar down without mechanical stretching, requiring reoperation.

But that logic rested more on surgical tradition than evidence. Recent data now challenge whether routine dilations are necessary at all, and whether the psychological cost to families justifies a practice whose benefit has never been rigorously proven 2:09.

The Clinical Problem

The feared complication is neoanal stricture — narrowing of the surgically created anus to the point where stool cannot pass normally 1:02. Strictures requiring reoperation represent a technical failure of the initial repair 1:02. The question is whether home dilations prevent this outcome, or whether strictures develop (or don't) based on factors unrelated to dilation protocols 0:53 1:02.

The traditional protocol, exemplified by a Spanish study, started dilations two weeks after PSARP, performed twice daily, with Hegar dilator size increased by 1 millimeter each week until reaching the target diameter 0:40 0:45. This meant months of twice-daily procedures performed by parents on infants and toddlers 0:40 0:45.

What the Evidence Shows

A single-institution review compared outcomes in children under 2 years, half of whom received dilations and half who did not 0:53. The stricture rate requiring reoperation was identical: two children in each group 1:02. Approximately 15% of children in the study required a Heineke-Mikulicz anoplasty for skin-level strictures 1:02 — a rate that did not differ between the dilation and observation groups 1:02.

This is not a randomized trial, and selection bias likely influenced which children received dilations 0:53. But the finding that stricture rates were equivalent raises the possibility that dilations prevent nothing, or that they prevent strictures only in a subset of patients we cannot currently identify prospectively 1:02.

What is clearer is the cost. Data support significant parental anxiety associated with performing dilations 0:30. Both patients and caregivers experience PTSD related to the procedure 0:33. Parents express fear that they will hurt their child or damage the surgical repair 0:37. These are not minor concerns — they represent ongoing trauma in families already managing a complex congenital condition 0:30 0:33 0:37.

The Alternative Approach

For skin-level strictures that do develop, the Heineke-Mikulicz anoplasty (HMA) offers a minimally invasive solution 1:34. The procedure involves making incisions at the 12, 3, 6, and 9 o'clock positions around the anal opening, creating a rhomboid shape that releases the strictured area 1:20. It requires no flaps and no rectal mobilization 1:30, can be performed as an outpatient procedure 1:38, and is described as safe, effective, and minimally invasive 1:34.

The strategic question becomes: is it better to subject all families to months of dilations to potentially prevent strictures in a minority of patients, or to observe all patients and perform HMA in those who develop strictures 1:02 1:34? The latter approach trades a guaranteed burden on all families for a surgical procedure in a minority 0:30 1:02.

Current Practice Patterns

Practice remains variable and is influenced by factors beyond the evidence 1:46 1:57. One surgeon dilates neonates but not older children, redo cases, or ambulatory patients, citing trauma concerns in the latter groups 1:46 1:49. Another dilates all neonatal cases, but notes that limited access to elective operating room time influences the decision — if scheduling an HMA later will be difficult, dilating up front becomes pragmatic 1:57 2:00.

This is honest: when system constraints make it hard to bring a child back for a simple outpatient procedure, the calculus shifts 2:00. The decision is not purely clinical 2:00.

When to Involve Colorectal Surgery

For the referring clinician, the relevant question is when to escalate concern about a child with a history of PSARP. Any child with difficulty stooling, visible narrowing of the anal opening, or pain with defecation after PSARP warrants colorectal surgery evaluation 1:02 1:02. These are not subtle findings — parents will report them 0:37. The window for HMA is wide; this is not an emergency, but it should not be normalized as an expected part of recovery 1:34 1:38.

If you are counseling a family preoperatively about what to expect after PSARP, the honest answer is now contested 2:09. There is not strong evidence to support mandatory anal dilation 2:09, and dilations cause stress for families 2:09. Age of the patient and access to outpatient procedures are considerations in the decision 2:17, but these are logistical, not clinical, factors 2:00 2:17. A family asking whether dilations are necessary is asking a question the field has not definitively answered 2:09.